Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04928326 · ClinicalTrials.gov registry record

Comparison of CorWatch With Right Heart Catheter Measurements in Heart Failure

A clinical trial of Heart Failure, sponsored by InCardia.

Completed
Registry status
43
Enrollment target
1
Study location

NCT04928326: Completed study of Heart Failure, sponsored by InCardia.

NCT04928326 is a study of Heart Failure that has completed, run by InCardia. The registered enrollment target is 43 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04928326, a study of Heart Failure, has completed, sponsored by InCardia.

COMPLETED
Registry status
43 participants
Enrollment target
1
Study location

Study Summary

This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a cardiac catheterization laboratory (cath lab) and in a cardiac intensive care unit (ICU).

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST CorWatch

Study Locations (1)

California

  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2021-08-01
Est. Completion 2022-10-01

Sponsor

InCardia

1 total trials

What the Registry Record Tells You About NCT04928326

The ClinicalTrials.gov registry entry for NCT04928326 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The listed sponsor is InCardia, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CorWatch is the first listed.

NCT04928326 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04928326 about?

NCT04928326 is a clinical study titled "Comparison of CorWatch With Right Heart Catheter Measurements in Heart Failure". This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a ca...

What is the current status of trial NCT04928326?

This trial is currently completed. The enrollment target is 43 participants. The study started on 2021-08-01. Estimated completion is 2022-10-01.

What conditions does trial NCT04928326 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT04928326?

The interventions under investigation include: CorWatch (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04928326?

This trial is sponsored by InCardia, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04928326 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.